世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

創傷治療市場:製品毎(泡、ヒドロコロイド、アルギン酸塩、抗菌包帯、NPWT、テープなど)、創傷毎(手術、トラウマ、糖尿病性病変、火傷)、エンドユーザ毎、地域毎 - 2024年までの世界市場予測

Wound Care Market by Product (Foams, Hydrocolloids, Alginates, Antimicrobial Dressings, Assessment, NPWT Devices, Substitutes, Sutures, Staples, Tapes), Wound (Surgical, Trauma, Diabetic Ulcers, Burns), End-User, Region - Global Forecast to 2024

 

出版社 出版年月電子版価格 ページ数図表数
MarketsandMarkets
マーケッツアンドマーケッツ
2019年9月US$8,150
シングルユーザライセンス
304 423

サマリー

幅広い市場に関する調査レポートを出版しているマーケッツアンドマーケッツ(MarketsandMarkets)の創傷治療市場に関する調査レポートです。

“Wound care market to register a CAGR of 4.6% from 2019 to 2024”

The global wound care market is projected to reach USD 24.8 billion by 2024 from USD 19.8 billion in 2019, growing at a CAGR of 4.6% from 2019 to 2024. The growth of the industry is driven primarily by factors such as rising incidences of road accidents & injuries, growing use of regenerative medicine, and increasing prevalence of conditions that impair wound healing capabilities. Increasing research in the field of advanced wound care and the growing popularity of active wound care products will further provide opportunities in the wound care industry. Developing economies are expected to offer a wide range of growth opportunities for players in the market.

“Advanced wound care products accounted for a significant share of the market in 2019”

Based on the product, the wound care market is segmented into advanced wound care, surgical wound care, and traditional wound care products. Advanced wound care products are anticipated to be the fastest-growing segment due to the rising incidence of hard-to-heal wounds and their growing adoption (due to their high efficacy).

“Diabetic foot ulcers segment accounted for the largest share of the wound care market in 2019”

Based on wound type, the wound care market is segmented into diabetic foot ulcers, pressure ulcers, surgical & traumatic wounds, venous leg ulcers, burns, and other wounds. Of these, the diabetic foot ulcers segment is expected to account for the largest share of the wound care market due to increased emphasis on aggressive management to prevent diabetic foot ulceration and foot amputation, using advanced and active wound care products.

“Home settings segment accounted for the highest CAGR of the wound care market in 2019”

Based on end-user, the wound care market is categorized into hospitals & clinics, long-term care facilities, and home care settings. Of all these end-user segments, home settings will grow at the fastest CAGR in the wound care market in 2019. The high growth of the home care settings segment is attributed to the growing incidence of chronic diseases and the rising need for comfortable and convenient care services among the rapidly growing geriatric population worldwide.

“North America dominated the wound care market in 2019”

North America, which includes the US, and Canada, accounted for the largest share of the wound care market. The rising incidence of diabetes, growing geriatric population, the presence of major manufacturers in the region, and easy access & rapid adoption of advanced products and technologies are driving the growth of this region

Breakdown of supply-side primary interviews, by company type, designation, and region:

- By Company Type: Tier 1 (20%) , Tier 2 (45%), and Tier 3 (35%)
- By Designation: C-level (30%), Director-level (20%), and Others (50%)
- By Region: North America (35%), Europe (24%), Asia Pacific (25%), and RoW (16%)

The key players operating in this market include Smith & Nephew plc (UK), Acelity L.P. Inc. (US), M-lnlycke Health Care AB (Subsidiary of Investor AB) (Sweden), Ethicon, Inc. (A Subsidiary of Johnson & Johnson ) (US), Convatec Group Plc (UK), Baxter International Inc. (US), Coloplast A/S (Denmark), Paul Hartmann AG (Germany), Medtronic plc (Ireland), 3M Company (US), Integra LifeSciences Holding Corporation (US), Mimedx Group (US), Lohmann & Rauscher International GmbH & Co. KG (Germany), DeRoyal Industries, Inc. (US), Organogenesis Holdings Inc. (US), Kerecis (Iceland), ACell (US), IonMed (Israel), Talley Group Ltd (UK), Medela AG (Switzerland).Product launches, expansions, agreements, and acquisitions are the key growth strategies followed by most players in this market.

Research Coverage

This report studies the wound care market based on the product, wound type, end-user, and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micro-markets with respect to their growth trends, prospects, and contributions to the total wound care market. The report forecasts the revenue of the market segments with respect to four major regions.
 
Reasons to Buy the Report:

The report provides insights on the following pointers:

- Market Penetration: Comprehensive information on the wound care products offered by the key 20 players in the wound care market. The report analyzes the wound care market by product, wound type,  end-user, and region.

- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various wound care products, their adoption, type of applications across key geographic regions.

- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the wound care market

- Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the wound care market along with a competitive leadership mapping of up to 25 players in the market and 15 Start-Ups in the market.



目次

TABLE OF CONTENTS

1 INTRODUCTION 31
1.1 OBJECTIVES OF THE STUDY 31
1.2 MARKET DEFINITION 31
1.3 MARKET SCOPE 32
1.3.1 MARKETS COVERED 32
1.3.2 YEARS CONSIDERED FOR THE STUDY 33
1.4 CURRENCY 33
1.5 LIMITATIONS 33
1.6 STAKEHOLDERS 34
2 RESEARCH METHODOLOGY 35
2.1 RESEARCH DATA 35
2.2 SECONDARY DATA 36
2.2.1 SECONDARY SOURCES 36
2.3 PRIMARY SOURCES 37
2.4 MARKET SIZE ESTIMATION 39
2.4.1 BOTTOM-UP APPROACH 39
2.4.2 TOP-DOWN APPROACH 40
2.4.3 GROWTH FORECAST 40
2.5 MARKET BREAKDOWN & DATA TRIANGULATION 40
2.6 MARKET SHARE ESTIMATION 42
3 EXECUTIVE SUMMARY 43
4 PREMIUM INSIGHTS 46
4.1 WOUND CARE MARKET OVERVIEW 46
4.2 NORTH AMERICA: WOUND CARE MARKET, BY END USER (2018) 47
4.3 WOUND CARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 48
5 MARKET OVERVIEW 49
5.1 INTRODUCTION 49
5.2 MARKET DYNAMICS 49
5.2.1 DRIVERS 50
5.2.1.1 Growing prevalence of diseases and conditions affecting wound healing capabilities 50
5.2.1.2 Increasing funding for wound care research 51
5.2.1.3 Road accidents and trauma injuries 52
5.2.1.4 Rising use of regenerative medicine in wound management 52
5.2.2 MARKET RESTRAINTS 53
5.2.2.1 High cost of advanced wound care products 53
5.2.2.2 Risks associated with wound care products 53
5.2.3 MARKET OPPORTUNITIES 54
5.2.3.1 AI in wound management 54
5.2.3.2 Increasing research in the field of advanced wound care 54
5.2.3.3 Potential applications of stem cell therapy in wound care 56
5.2.3.4 Emerging economies 57
5.2.4 MARKET TRENDS 58
5.2.4.1 Increasing number of acquisitions 58
5.2.4.2 Focus on expanding capabilities of current technologies and products 58
5.2.4.2.1 Crab shell bandages 59
5.2.4.2.2 Keratin-based wound management 59
5.2.4.2.3 Pharmacological therapies 59
5.2.4.2.4 Smart bandages 59
5.3 REGULATORY PATHWAYS FOR WOUND CARE PRODUCTS 60
6 WOUND CARE MARKET, BY PRODUCT 61
6.1 INTRODUCTION 62
6.2 ADVANCED WOUND CARE PRODUCTS 62
6.2.1 ADVANCED WOUND DRESSINGS 64
6.2.1.1 Foam dressings 65
6.2.1.1.1 Foam dressings are extensively used for a large variety of wounds—a major factor contributing to the large share of this market 65
6.2.1.1.2 Silicone dressings 67
6.2.1.1.3 Non-silicone dressings 68
6.2.1.2 Hydrocolloid dressings 68
6.2.1.2.1 Hydrocolloid dressings can be left on the wound for longer durations, which makes them cost-effective—a key factor driving the uptake of these products 68
6.2.1.3 Film dressings 70
6.2.1.3.1 Due to their non-absorbable nature, film dressings are not used for treating exuding wounds, which could limit adoption to a certain extent 70
6.2.1.4 Alginate dressings 71
6.2.1.4.1 Alginate dressings are well-suited for pressure and diabetic foot ulcers 71
6.2.1.5 Hydrogel dressings 72
6.2.1.5.1 Hydrogel dressings are available in several forms for effective use 72
6.2.1.6 Antimicrobial dressings 74
6.2.1.6.1 High effectiveness in microbe removal has driven product demand 74
6.2.1.7 Collagen dressings 75
6.2.1.7.1 Favorable reimbursement scenario for collagen dressings has greatly boosted their use 75
6.2.1.8 Hydrofiber dressings 76
6.2.1.8.1 Hydrofiber dressings combine the properties of hydrocolloids and alginates 76
6.2.1.9 Wound contact layers 77
6.2.1.9.1 Wound contact layers protect wound beds from bacterial and fungal growth 77
6.2.1.10 Superabsorbent dressings 78
6.2.1.10.1 Superabsorbent dressings are used where adhesive dressings may cause damage 78
6.2.2 WOUND THERAPY DEVICES 79
6.2.2.1 Pressure relief devices 80
6.2.2.1.1 High device costs and lack of reimbursement may hamper market growth 80
6.2.2.2 Wound assessment & monitoring devices 81
6.2.2.2.1 Potential cost-reducing capabilities of wound assessment and monitoring devices will boost their adoption 81
6.2.2.3 Negative pressure wound therapy systems 82
6.2.2.3.1 Conventional NPWT systems 84
6.2.2.3.1.1 High effectiveness in managing highly exuding wounds has driven the demand for conventional NPWT systems 84
6.2.2.3.2 Disposable NPWT systems 84
6.2.2.3.2.1 Disposable NPWT systems are difficult to handle when treating large wounds and have greater negative pressure requirements, which could limit their adoption to a certain extent 84
6.2.2.3.3 Accessories 85
6.2.2.4 Oxygen & hyperbaric oxygen equipment 86
6.2.2.4.1 Although hyperbaric oxygen treatment helps in rapid healing, there are absolute contraindications for this therapy in patients with untreated pneumothorax, which could limit adoption 86
6.2.2.5 Other wound therapy devices 87
6.2.3 ACTIVE WOUND CARE PRODUCTS 88
6.2.3.1 Biological skin substitutes 89
6.2.3.1.1 Human donor tissue-derived products 90
6.2.3.1.1.1 Low rejection rate and high efficacy have boosted the adoption of tissue-derived products 90
6.2.3.1.2 Acellular animal-derived products 91
6.2.3.1.2.1 Some acellular xenografts have a high rejection rate, which may affect market growth 91
6.2.3.1.3 Biosynthetic products 92
6.2.3.1.3.1 Biosynthetic products leave no residue and are cost-effective, which contribute to the high adoption of these products 92

6.2.3.2 Topical agents 93
6.2.3.2.1 Formulation difficulties, the high cost of clinical trials with greater chances of failure, and the high cost of the final product are limiting factors for topical agents such as growth factors 93
6.3 SURGICAL WOUND CARE PRODUCTS 93
6.3.1 SUTURES 94
6.3.1.1 Increasing number of surgical procedures and the high tensile strength afforded by sutures are key factors driving product adoption 94
6.3.2 STAPLERS 95
6.3.2.1 Staplers are considered to be more accurate than suturing and less likely to allow leakage, resulting in higher product adoption 95
6.3.3 TISSUE ADHESIVES, SEALANTS, & GLUES 96
6.3.3.1 Fibrin-based sealants 97
6.3.3.1.1 Fibrin-based sealants provide better results than sutures, which has driven product demand 97
6.3.3.2 Collagen-based sealants 98
6.3.3.2.1 Collagen-based products are used in surgical procedures as an adjunctive to hemostatic agents and are used when bleeding cannot be controlled effectively through conventional methods 98
6.3.3.3 Synthetic adhesives 98
6.3.3.3.1 Advantage of using synthetic tissue adhesives over traditional staples is that synthetics have additional sealing properties as compared to traditional staples 98
6.3.4 ANTI-INFECTIVE DRESSINGS 99
6.3.4.1 Need to prevent hospital-associated infections has driven demand in this market 99
6.4 TRADITIONAL WOUND CARE PRODUCTS 100
6.4.1 MEDICAL TAPES 101
6.4.1.1 Latex-free tapes are gentle to the skin and hypoallergenic for sensitive patients—key advantages leading to high adoption of these products 101
6.4.2 DRESSINGS 101
6.4.2.1 Presence of a large patient population for pressure ulcers (in which dry dressings are extensively used) has ensured a sustained demand for these products 101
6.4.3 CLEANSING AGENTS 102
6.4.3.1 High risk of HAIs from open wounds will drive the market for cleansing agents 102
7 WOUND CARE MARKET, BY WOUND TYPE 104
7.1 INTRODUCTION 105
7.2 DIABETIC FOOT ULCERS 105
7.2.1 INCREASED EMPHASIS ON AGGRESSIVE WOUND MANAGEMENT TO PREVENT DIABETIC FOOT ULCERATION AND FOOT AMPUTATION TO DRIVE GROWTH IN THIS MARKET SEGMENT 105

7.3 PRESSURE ULCERS 106
7.3.1 HIGH SUSCEPTIBILITY TO PRESSURE ULCERS HAS MADE GERIATRICS KEY CONSUMERS OF WOUND CARE PRODUCTS 106
7.4 SURGICAL & TRAUMATIC WOUNDS 107
7.4.1 GROWING NUMBER OF SURGICAL PROCEDURES IS A MAJOR FACTOR DRIVING THE DEMAND FOR WOUND CARE PRODUCTS IN SURGICAL WOUND APPLICATIONS 107
7.5 VENOUS LEG ULCERS 108
7.5.1 INCIDENCE OF LEG ULCERS IS INCREASING DUE TO THE GROWING GERIATRIC POPULATION AND INCREASING RISK FACTORS FOR ATHEROSCLEROTIC OCCLUSION 108
7.6 BURNS 109
7.6.1 THE INCIDENCE OF BURN INJURIES IS HIGH IN THE US, AND A LARGE VOLUME OF WOUND CARE PRODUCTS IS CONSUMED FOR THEIR TREATMENT—A MAJOR MARKET DRIVER 109
7.7 OTHER WOUNDS 110
8 WOUND CARE MARKET, BY END USER 111
8.1 INTRODUCTION 112
8.2 HOSPITALS & CLINICS 112
8.2.1 INPATIENT SETTINGS 113
8.2.1.1 Increasing hospital admissions due to chronic wounds and the rising incidence of hospital-acquired pressure ulcers are key drivers for the growth of this end-user segment 113
8.2.2 OUTPATIENT SETTINGS 114
8.2.2.1 Increasing costs of inpatient care have shifted attention toward outpatient settings 114
8.3 LONG-TERM CARE FACILITIES 115
8.3.1 GROWTH IN THE GERIATRIC AND VULNERABLE POPULATIONS ARE DRIVING THE DEMAND FOR BETTER LONG-TERM CARE 115
8.4 HOME CARE SETTINGS 116
8.4.1 DECREASED COSTS AND HIGHER CONVENIENCE AND COMFORT OF HOME CARE WILL ENSURE MARKET GROWTH IN THIS SEGMENT 116
9 WOUND CARE MARKET, BY REGION 117
9.1 INTRODUCTION 118
9.2 NORTH AMERICA 118
9.2.1 US 124
9.2.1.1 Rising incidence of chronic diseases and diabeties is a major driver for the growth of wound care market in the US 124
9.2.2 CANADA 129
9.2.2.1 Rising prevelance of diabeties to drive the growth of wound care market in Canada 129
9.3 EUROPE 134
9.3.1 GERMANY 140
9.3.1.1 Large diabetic population has supported product development and commercialization efforts in Germany 140
9.3.2 UK 145
9.3.2.1 Rising incidence of chronic wounds and growing R&D focus have supported market growth in the UK 145
9.3.3 FRANCE 151
9.3.3.1 Players in this market are focusing on enhancing their product portfolios and presence in France 151
9.3.4 ITALY 156
9.3.4.1 Unfavorable reimbursement scenario for advanced wound care will hinder market growth in Italy 156
9.3.5 SPAIN 160
9.3.5.1 Increasing life expectancies and the growing geriatric population will favor product demand in Spain 160
9.3.6 RUSSIA 165
9.3.6.1 Government focus on increasing diabetes awareness will favor market growth in Russia 165
9.3.7 REST OF EUROPE 169
9.4 ASIA PACIFIC 173
9.4.1 JAPAN 180
9.4.1.1 Favorable regulations in Japan have resulted in increased product launches and commercialization 180
9.4.2 CHINA 184
9.4.2.1 Growing focus of companies on the emerging Chinese market is a major factor supporting the growth of the wound care market in the country 184
9.4.3 INDIA 189
9.4.3.1 Investments by international firms have supported market growth in India 189
9.4.4 AUSTRALIA 195
9.4.4.1 Growing awareness of diabetes management will support market growth in Australia 195
9.4.5 SOUTH KOREA 200
9.4.5.1 Local manufacturers in South Korea are partnering with research organizations for product development 200
9.4.6 SINGAPORE 205
9.4.6.1 Growing prevalence of diabetes is a major driver for the growth of the wound care market in Singapore 205
9.4.7 REST OF ASIA PACIFIC 209
9.5 LATIN AMERICA 213
9.5.1 BRAZIL 219
9.5.1.1 Brazil is one of the largest markets for healthcare in the Latin American region 219
9.5.2 MEXICO 222
9.5.2.1 Diabetes is the second-highest cause of mortality in Mexico 222
9.5.3 REST OF LATIN AMERICA 226

9.6 MIDDLE EAST & AFRICA 229
9.6.1 WITH RISING DIABETES PREVALENCE IN THIS REGION, THE PREVALENCE OF CONDITIONS SUCH AS LEG ULCERS IS ON THE RISE, WHICH IS A POSITIVE INDICATOR FOR MARKET GROWTH 229
10 COMPETITIVE LANDSCAPE 235
10.1 OVERVIEW 235
10.2 MARKET SHARE ANALYSIS 236
10.2.1 NEGATIVE PRESSURE WOUND THERAPY SYSTEMS 236
10.2.2 ADVANCED WOUND DRESSINGS 236
10.2.3 ACTIVE WOUND CARE PRODUCTS 237
10.2.4 TRADITIONAL AND SURGICAL WOUND CARE PRODUCTS 237
10.2.5 SURGICAL SUTURES 238
10.3 COMPETITIVE SCENARIO 238
10.3.1 PARTNERSHIPS, AGREEMENTS, CONTRACTS, & COLLABORATIONS 238
10.3.2 PRODUCT LAUNCHES, UPGRADES, & APPROVALS 239
10.3.3 ACQUISITIONS 239
10.3.4 EXPANSIONS 240
10.4 COMPETITIVE LEADERSHIP MAPPING 240
10.4.1 VISIONARY LEADERS 240
10.4.2 INNOVATORS 240
10.4.3 DYNAMIC DIFFERENTIATORS 240
10.4.4 EMERGING COMPANIES 240
10.5 COMPETITIVE LEADERSHIP MAPPING (START-UPS) 242
10.5.1 PROGRESSIVE COMPANIES 242
10.5.2 STARTING BLOCKS 242
10.5.3 RESPONSIVE COMPANIES 242
10.5.4 DYNAMIC COMPANIES 242
10.6 MNM DIVE: VENDOR COMPARISON MATRIX FOR START-UPS 243
11 COMPANY PROFILES 244
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
11.1 SMITH & NEPHEW PLC 244
11.2 MÖLNLYCKE HEALTH CARE AB 248
11.3 BAXTER INTERNATIONAL INC. 252
11.4 ACELITY L.P. INC. 255
11.5 INTEGRA LIFESCIENCES HOLDING CORPORATION 258
11.6 CONVATEC GROUP 261
11.7 COLOPLAST A/S 264
11.8 ETHICON INC. 266
11.9 MEDTRONIC PLC 269
11.10 3M COMPANY 272
11.11 PAUL HARTMANN AG 275
11.12 MIMEDX GROUP 277
11.13 DEROYAL INDUSTRIES 278
11.14 ORGANOGENESIS HOLDINGS INC. 281
11.15 KERECIS 283
11.16 ACELL 285
11.17 LOHMANN & RAUSCHER INTERNATIONAL GMBH & CO. KG 287
11.18 MEDELA AG 289
11.19 TALLEY GROUP 290
11.20 IONMED INC. 291
*Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.
12 APPENDIX 292
12.1 INDUSTRY INSIGHTS 292
12.2 DISCUSSION GUIDE 293
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 300
12.4 AVAILABLE CUSTOMIZATIONS 302
12.5 RELATED REPORTS 302
12.6 AUTHOR DETAILS 303   

 

LIST OF TABLES

TABLE 1 AGE-SPECIFIC PREVALENCE OF DIABETIC FOOT ULCERS, BY GENDER 51
TABLE 2 FUNDING INITIATIVES FOR WOUND CARE RESEARCH 51
TABLE 3 RISKS ASSOCIATED WITH WOUND CARE PRODUCTS 53
TABLE 4 TOP APPLICANTS FOR SEVERAL PATENTS 55
TABLE 5 APPLICANTS OF WOUND-HEALING PATENTS, BY GROUP 56
TABLE 6 TOP FIVE APPLICANTS AT EACH PATENT OFFICE (2017) 56
TABLE 7 CLINICAL TRIALS FOR STEM CELL-BASED THERAPIES FOR WOUND HEALING 57
TABLE 8 STRATEGIC DEVELOPMENTS IN ASIA PACIFIC 57
TABLE 9 REGULATORY PATHWAYS FOR WOUND CARE PRODUCT CATEGORIES IN THE US 60
TABLE 10 WOUND CARE MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 62
TABLE 11 ADVANCED WOUND CARE PRODUCTS MARKET: COMPANY PORTFOLIO ANALYSIS 63
TABLE 12 ADVANCED WOUND CARE PRODUCTS MARKET, BY REGION,
2017–2024 (USD MILLION) 63
TABLE 13 ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 63
TABLE 14 ADVANCED WOUND DRESSINGS MARKET, BY REGION, 2017–2024 (USD MILLION) 64
TABLE 15 ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2017–2024 (USD MILLION) 65
TABLE 16 KEY PLAYERS IN THE FOAM DRESSINGS MARKET 66
TABLE 17 FOAM DRESSINGS MARKET, BY TYPE, 2017–2024 (USD MILLION) 66
TABLE 18 FOAM DRESSINGS MARKET, BY REGION, 2017–2024 (USD MILLION) 67
TABLE 19 SILICONE DRESSINGS MARKET, BY REGION, 2017–2024 (USD MILLION) 67
TABLE 20 NON-SILICONE DRESSINGS MARKET, BY REGION, 2017–2024 (USD MILLION) 68
TABLE 21 KEY PLAYERS IN THE HYDROCOLLOID DRESSINGS MARKET 69
TABLE 22 HYDROCOLLOID DRESSINGS MARKET, BY REGION, 2017–2024 (USD MILLION) 69
TABLE 23 KEY PLAYERS IN THE FILM DRESSINGS MARKET 70
TABLE 24 FILM DRESSINGS MARKET, BY REGION, 2017–2024 (USD MILLION) 70
TABLE 25 KEY PLAYERS IN THE ALGINATE DRESSINGS MARKET 71
TABLE 26 ALGINATE DRESSINGS MARKET, BY REGION, 2017–2024 (USD MILLION) 72
TABLE 27 KEY PLAYERS IN THE HYDROGEL DRESSINGS MARKET 73
TABLE 28 HYDROGEL DRESSINGS MARKET, BY REGION, 2017–2024 (USD MILLION) 73
TABLE 29 KEY PLAYERS IN THE ANTIMICROBIAL DRESSINGS MARKET 74
TABLE 30 ANTIMICROBIAL FOAM DRESSINGS, BY REGION, 2017–2024 (USD MILLION) 75
TABLE 31 KEY PLAYERS IN THE COLLAGEN DRESSINGS MARKET 76
TABLE 32 COLLAGEN DRESSINGS MARKET, BY REGION, 2017–2024 (USD MILLION) 76
TABLE 33 HYDROFIBER DRESSINGS MARKET, BY REGION, 2017–2024 (USD MILLION) 77
TABLE 34 WOUND CONTACT LAYERS MARKET, BY REGION, 2017–2024 (USD MILLION) 77
TABLE 35 KEY PLAYERS IN THE SUPERABSORBENT DRESSINGS MARKET 78
TABLE 36 SUPERABSORBENT DRESSINGS MARKET, BY REGION, 2017–2024 (USD MILLION) 78
TABLE 37 WOUND THERAPY DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION) 79
TABLE 38 WOUND THERAPY DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 79
TABLE 39 PRESSURE RELIEF DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION) 80
TABLE 40 WOUND ASSESSMENT & MONITORING DEVICES MARKET, BY REGION,
2017–2024 (USD MILLION) 81
TABLE 41 CONVENTIONAL VS. DISPOSABLE/SINGLE-USE SYSTEMS 82
TABLE 42 NPWT SYSTEMS MARKET, BY REGION, 2017–2024 (USD MILLION) 83
TABLE 43 NPWT SYSTEMS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 83
TABLE 44 CONVENTIONAL NPWT SYSTEMS MARKET, BY REGION,
2017–2024 (USD MILLION) 84
TABLE 45 DISPOSABLE NPWT SYSTEMS MARKET, BY REGION, 2017–2024 (USD MILLION) 85
TABLE 46 ACCESSORIES MARKET, BY REGION, 2017–2024 (USD MILLION) 85
TABLE 47 OXYGEN & HYPERBARIC OXYGEN EQUIPMENT MARKET, BY REGION,
2017–2024 (USD MILLION) 86
TABLE 48 OTHER WOUND THERAPY DEVICES MARKET, BY REGION,
2017–2024 (USD MILLION) 87
TABLE 49 ACTIVE WOUND CARE PRODUCTS MARKET, BY REGION,
2017–2024 (USD MILLION) 88
TABLE 50 ACTIVE WOUND CARE PRODUCTS MARKET, BY TYPE, 2017–2024 (USD MILLION) 88
TABLE 51 BIOLOGICAL SKIN SUBSTITUTES COMMERCIALIZED FOR WOUND TREATMENT 89
TABLE 52 BIOLOGICAL SKIN SUBSTITUTES MARKET, BY REGION, 2017–2024 (USD MILLION) 89
TABLE 53 BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2017–2024 (USD MILLION) 90
TABLE 54 COMMERCIALIZED HUMAN-DONOR TISSUE-DERIVED PRODUCTS 90
TABLE 55 HUMAN DONOR TISSUE-DERIVED PRODUCTS MARKET, BY REGION,
2017–2024 (USD MILLION) 91
TABLE 56 COMMERCIALIZED ACELLULAR ANIMAL-DERIVED PRODUCTS 91
TABLE 57 ACELLULAR ANIMAL-DERIVED PRODUCTS MARKET, BY REGION,
2017–2024 (USD MILLION) 92
TABLE 58 BIOSYNTHETIC PRODUCTS MARKET, BY REGION, 2017–2024 (USD MILLION) 92
TABLE 59 TOPICAL AGENTS MARKET, BY REGION, 2017–2024 (USD MILLION) 93
TABLE 60 SURGICAL WOUND CARE PRODUCTS MARKET, BY REGION,
2017–2024 (USD MILLION) 94
TABLE 61 SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 94
TABLE 62 SUTURES MARKET, BY REGION, 2017–2024 (USD MILLION) 95
TABLE 63 STAPLERS MARKET, BY REGION, 2017–2024 (USD MILLION) 96
TABLE 64 TISSUE ADHESIVES, SEALANTS, & GLUES MARKET, BY REGION,
2017–2024 (USD MILLION) 96
TABLE 65 TISSUE ADHESIVES, SEALANTS, & GLUES MARKET, BY TYPE,
2017–2024 (USD MILLION) 97
TABLE 66 FIBRIN-BASED SEALANTS MARKET, BY REGION, 2017–2024 (USD MILLION) 97
TABLE 67 COLLAGEN-BASED SEALANTS MARKET, BY REGION, 2017–2024 (USD MILLION) 98
TABLE 68 SYNTHETIC ADHESIVES MARKET, BY REGION, 2017–2024 (USD MILLION) 99
TABLE 69 ANTI-INFECTIVE DRESSINGS MARKET, BY REGION, 2017–2024 (USD MILLION) 99
TABLE 70 TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 100
TABLE 71 TRADITIONAL WOUND CARE PRODUCTS MARKET, BY REGION,
2017–2024 (USD MILLION) 100
TABLE 72 MEDICAL TAPES MARKET, BY REGION, 2017–2024 (USD MILLION) 101
TABLE 73 DRESSINGS MARKET, BY REGION, 2017–2024 (USD MILLION) 102
TABLE 74 TYPES OF CLEANSING AGENTS 102
TABLE 75 CLEANSING AGENTS MARKET, BY REGION, 2017–2024 (USD MILLION) 103
TABLE 76 WOUND CARE MARKET, BY WOUND TYPE, 2017–2024 (USD MILLION) 105
TABLE 77 WOUND CARE MARKET FOR DIABETIC FOOT ULCERS, BY REGION,
2017–2024 (USD MILLION) 106
TABLE 78 WOUND CARE MARKET FOR PRESSURE ULCERS, BY REGION,
2017–2024 (USD MILLION) 107
TABLE 79 WOUND CARE MARKET FOR SURGICAL & TRAUMATIC WOUNDS,
BY REGION, 2017–2024 (USD MILLION) 108
TABLE 80 WOUND CARE MARKET FOR VENOUS LEG ULCERS, BY REGION,
2017–2024 (USD MILLION) 109
TABLE 81 HOSPITAL ADMISSIONS FOR THE TREATMENT OF BURN INJURIES, 2015 109
TABLE 82 WOUND CARE MARKET FOR BURNS, BY REGION, 2017–2024 (USD MILLION) 110
TABLE 83 WOUND CARE MARKET FOR OTHER WOUNDS, BY REGION,
2017–2024 (USD MILLION) 110
TABLE 84 WOUND CARE MARKET, BY END USER, 2017–2024 (USD MILLION) 112
TABLE 85 WOUND CARE MARKET FOR HOSPITALS & CLINICS, BY REGION,
2017–2024 (USD MILLION) 113
TABLE 86 WOUND CARE MARKET FOR HOSPITALS & CLINICS, BY SETTING,
2017–2024 (USD MILLION) 113
TABLE 87 WOUND CARE MARKET FOR INPATIENT SETTINGS, BY REGION,
2017–2024 (USD MILLION) 114
TABLE 88 WOUND CARE MARKET FOR OUTPATIENT SETTINGS, BY REGION,
2017–2024 (USD MILLION) 114
TABLE 89 WOUND CARE MARKET FOR LONG-TERM CARE FACILITIES, BY REGION,
2017–2024 (USD MILLION) 115
TABLE 90 WOUND CARE MARKET FOR HOME CARE SETTINGS, BY REGION,
2017–2024 (USD MILLION) 116
TABLE 91 WOUND CARE MARKET, BY REGION, 2017–2024 (USD MILLION) 118
TABLE 92 NORTH AMERICA: WOUND CARE MARKET, BY COUNTRY,
2017–2024 (USD MILLION) 119
TABLE 93 NORTH AMERICA: WOUND CARE MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 120
TABLE 94 NORTH AMERICA: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 120
TABLE 95 NORTH AMERICA: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2017–2024 (USD MILLION) 120
TABLE 96 NORTH AMERICA: FOAM DRESSINGS MARKET, BY TYPE,
2017–2024 (USD MILLION) 121
TABLE 97 NORTH AMERICA: WOUND THERAPY DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 121
TABLE 98 NORTH AMERICA: NPWT SYSTEMS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 121
TABLE 99 NORTH AMERICA: ACTIVE WOUND CARE PRODUCTS MARKET,
BY TYPE, 2017–2024 (USD MILLION) 122
TABLE 100 NORTH AMERICA: BIOLOGICAL SKIN SUBSTITUTES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 122
TABLE 101 NORTH AMERICA: SURGICAL WOUND CARE PRODUCTS MARKET,
BY TYPE, 2017–2024 (USD MILLION) 122
TABLE 102 NORTH AMERICA: TISSUE ADHESIVES, SEALANTS, & GLUES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 123
TABLE 103 NORTH AMERICA: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2017–2024 (USD MILLION) 123
TABLE 104 NORTH AMERICA: WOUND CARE MARKET, BY WOUND TYPE,
2017–2024 (USD MILLION) 123
TABLE 105 NORTH AMERICA: WOUND CARE MARKET, BY END USER,
2017–2024 (USD MILLION) 124
TABLE 106 NORTH AMERICA: WOUND CARE MARKET FOR HOSPITALS & CLINICS, BY SETTING, 2017–2024 (USD MILLION) 124
TABLE 107 US: WOUND CARE MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 125
TABLE 108 US: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 125
TABLE 109 US: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2017–2024 (USD MILLION) 125
TABLE 110 US: FOAM DRESSINGS MARKET, BY TYPE, 2017–2024 (USD MILLION) 126
TABLE 111 US: WOUND THERAPY DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 126
TABLE 112 US: NPWT SYSTEMS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 126
TABLE 113 US: ACTIVE WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 127
TABLE 114 US: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 127
TABLE 115 US: TISSUE ADHESIVES, SEALANTS, & GLUES MARKET, BY TYPE,
2017–2024 (USD MILLION) 127
TABLE 116 US: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 128
TABLE 117 US: WOUND CARE MARKET, BY WOUND TYPE, 2017–2024 (USD MILLION) 128
TABLE 118 US: WOUND CARE MARKET, BY END USER, 2017–2024 (USD MILLION) 128
TABLE 119 US: WOUND CARE MARKET FOR HOSPITALS & CLINICS, BY SETTING,
2017–2024 (USD MILLION) 129
TABLE 120 INCIDENCE OF DIABETES IN CANADA 129
TABLE 121 CANADA: WOUND CARE MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 130
TABLE 122 CANADA: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 130
TABLE 123 CANADA: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2017–2024 (USD MILLION) 130
TABLE 124 CANADA: FOAM DRESSINGS MARKET, BY TYPE, 2017–2024 (USD MILLION) 131
TABLE 125 CANADA: WOUND THERAPY DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 131
TABLE 126 CANADA: NPWT SYSTEMS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 131
TABLE 127 CANADA: ACTIVE WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 132
TABLE 128 CANADA: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 132
TABLE 129 CANADA: TISSUE ADHESIVES, SEALANTS, & GLUES MARKET, BY TYPE,
2017–2024 (USD MILLION) 132
TABLE 130 CANADA: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 133
TABLE 131 CANADA: WOUND CARE MARKET, BY WOUND TYPE, 2017–2024 (USD MILLION) 133
TABLE 132 CANADA: WOUND CARE MARKET, BY END USER, 2017–2024 (USD MILLION) 133
TABLE 133 CANADA: WOUND CARE MARKET FOR HOSPITALS & CLINICS, BY SETTING,
2017–2024 (USD MILLION) 134
TABLE 134 PREVALENCE OF DIABETES IN EUROPE, 2015 VS. 2040 134
TABLE 135 EUROPE: WOUND CARE MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 135
TABLE 136 EUROPE: WOUND CARE MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 135
TABLE 137 EUROPE: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 136
TABLE 138 EUROPE: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2017–2024 (USD MILLION) 136
TABLE 139 EUROPE: FOAM DRESSINGS MARKET, BY TYPE, 2017–2024 (USD MILLION) 137
TABLE 140 EUROPE: WOUND THERAPY DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 137
TABLE 141 EUROPE: NPWT SYSTEMS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 137
TABLE 142 EUROPE: ACTIVE WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 138
TABLE 143 EUROPE: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE,
2017–2024 (USD MILLION) 138
TABLE 144 EUROPE: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 138
TABLE 145 EUROPE: TISSUE ADHESIVES, SEALANTS, & GLUES MARKET, BY TYPE,
2017–2024 (USD MILLION) 139
TABLE 146 EUROPE: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 139
TABLE 147 EUROPE: WOUND CARE MARKET, BY WOUND TYPE, 2017–2024 (USD MILLION) 139
TABLE 148 EUROPE: WOUND CARE MARKET, BY END USER, 2017–2024 (USD MILLION) 140
TABLE 149 EUROPE: WOUND CARE MARKET FOR HOSPITALS & CLINICS, BY SETTING,
2017–2024 (USD MILLION) 140
TABLE 150 GERMANY: WOUND CARE MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 141
TABLE 151 GERMANY: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 141
TABLE 152 GERMANY: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2017–2024 (USD MILLION) 142
TABLE 153 GERMANY: FOAM DRESSINGS MARKET, BY TYPE, 2017–2024 (USD MILLION) 142
TABLE 154 GERMANY: WOUND THERAPY DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 143
TABLE 155 GERMANY: ACTIVE WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 143
TABLE 156 GERMANY: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 143
TABLE 157 GERMANY: TISSUE ADHESIVES, SEALANTS, & GLUES MARKET, BY TYPE,
2017–2024 (USD MILLION) 144
TABLE 158 GERMANY: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 144
TABLE 159 GERMANY: WOUND CARE MARKET, BY WOUND TYPE, 2017–2024 (USD MILLION) 144
TABLE 160 GERMANY: WOUND CARE MARKET, BY END USER, 2017–2024 (USD MILLION) 145
TABLE 161 GERMANY: WOUND CARE MARKET FOR HOSPITALS & CLINICS, BY SETTING,
2017–2024 (USD MILLION) 145
TABLE 162 UK: WOUND CARE MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 146
TABLE 163 UK: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 146
TABLE 164 UK: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2017–2024 (USD MILLION) 147
TABLE 165 UK: FOAM DRESSINGS MARKET, BY TYPE, 2017–2024 (USD MILLION) 147
TABLE 166 UK: WOUND THERAPY DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 148
TABLE 167 UK: NPWT SYSTEMS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 148
TABLE 168 UK: ACTIVE WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 148
TABLE 169 UK: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 149
TABLE 170 UK: TISSUE ADHESIVES, SEALANTS, & GLUES MARKET, BY TYPE,
2017–2024 (USD MILLION) 149
TABLE 171 UK: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 149
TABLE 172 UK: WOUND CARE MARKET, BY WOUND TYPE, 2017–2024 (USD MILLION) 150
TABLE 173 UK: WOUND CARE MARKET, BY END USER, 2017–2024 (USD MILLION) 150
TABLE 174 UK: WOUND CARE MARKET FOR HOSPITALS & CLINICS, BY SETTING,
2017–2024 (USD MILLION) 150
TABLE 175 FRANCE: WOUND CARE MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 151
TABLE 176 FRANCE: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 151
TABLE 177 FRANCE: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2017–2024 (USD MILLION) 152
TABLE 178 FRANCE: FOAM DRESSINGS MARKET, BY TYPE, 2017–2024 (USD MILLION) 152
TABLE 179 FRANCE: WOUND THERAPY DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 153
TABLE 180 FRANCE: NPWT SYSTEMS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 153
TABLE 181 FRANCE: ACTIVE WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 153
TABLE 182 FRANCE: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 154
TABLE 183 FRANCE: TISSUE ADHESIVES, SEALANTS, & GLUES MARKET, BY TYPE,
2017–2024 (USD MILLION) 154
TABLE 184 FRANCE: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 154
TABLE 185 FRANCE: WOUND CARE MARKET, BY WOUND TYPE, 2017–2024 (USD MILLION) 155
TABLE 186 FRANCE: WOUND CARE MARKET, BY END USER, 2017–2024 (USD MILLION) 155
TABLE 187 FRANCE: WOUND CARE MARKET FOR HOSPITALS & CLINICS, BY SETTING,
2017–2024 (USD MILLION) 155
TABLE 188 ITALY: WOUND CARE MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 156
TABLE 189 ITALY: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 157
TABLE 190 ITALY: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2017–2024 (USD MILLION) 157
TABLE 191 ITALY: FOAM DRESSINGS MARKET, BY TYPE, 2017–2024 (USD MILLION) 158
TABLE 192 ITALY: WOUND THERAPY DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 158
TABLE 193 ITALY: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 158
TABLE 194 ITALY: TISSUE ADHESIVES, SEALANTS, & GLUES MARKET, BY TYPE,
2017–2024 (USD MILLION) 159
TABLE 195 ITALY: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 159
TABLE 196 ITALY: WOUND CARE MARKET, BY WOUND TYPE, 2017–2024 (USD MILLION) 159
TABLE 197 ITALY: WOUND CARE MARKET, BY END USER, 2017–2024 (USD MILLION) 160
TABLE 198 ITALY: WOUND CARE MARKET FOR HOSPITALS & CLINICS, BY SETTING,
2017–2024 (USD MILLION) 160
TABLE 199 SPAIN: WOUND CARE MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 161
TABLE 200 SPAIN: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 161
TABLE 201 SPAIN: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2017–2024 (USD MILLION) 162
TABLE 202 SPAIN: FOAM DRESSINGS MARKET, BY TYPE, 2017–2024 (USD MILLION) 162
TABLE 203 SPAIN: WOUND THERAPY DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 163
TABLE 204 SPAIN: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 163
TABLE 205 SPAIN: TISSUE ADHESIVES, SEALANTS, & GLUES MARKET, BY TYPE,
2017–2024 (USD MILLION) 163
TABLE 206 SPAIN: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 164
TABLE 207 SPAIN: WOUND CARE MARKET, BY WOUND TYPE, 2017–2024 (USD MILLION) 164
TABLE 208 SPAIN: WOUND CARE MARKET, BY END USER, 2017–2024 (USD MILLION) 164
TABLE 209 SPAIN: WOUND CARE MARKET FOR HOSPITALS & CLINICS, BY SETTING,
2017–2024 (USD MILLION) 165
TABLE 210 RUSSIA: WOUND CARE MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 165
TABLE 211 RUSSIA: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 166
TABLE 212 RUSSIA: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2017–2024 (USD MILLION) 166
TABLE 213 RUSSIA: FOAM DRESSINGS MARKET, BY TYPE, 2017–2024 (USD MILLION) 166
TABLE 214 RUSSIA: WOUND THERAPY DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 167
TABLE 215 RUSSIA: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 167
TABLE 216 RUSSIA: TISSUE ADHESIVES, SEALANTS, & GLUES MARKET, BY TYPE,
2017–2024 (USD MILLION) 167
TABLE 217 RUSSIA: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 168
TABLE 218 RUSSIA: WOUND CARE MARKET, BY WOUND TYPE, 2017–2024 (USD MILLION) 168
TABLE 219 RUSSIA: WOUND CARE MARKET, BY END USER, 2017–2024 (USD MILLION) 168
TABLE 220 RUSSIA: WOUND CARE MARKET FOR HOSPITALS & CLINICS, BY SETTING,
2017–2024 (USD MILLION) 169
TABLE 221 ROE: WOUND CARE MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 169
TABLE 222 ROE: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 170
TABLE 223 ROE: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2017–2024 (USD MILLION) 170
TABLE 224 ROE: FOAM DRESSINGS MARKET, BY TYPE, 2017–2024 (USD MILLION) 171
TABLE 225 ROE: WOUND THERAPY DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 171
TABLE 226 ROE: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 171
TABLE 227 ROE: TISSUE ADHESIVES, SEALANTS, & GLUES MARKET, BY TYPE,
2017–2024 (USD MILLION) 172
TABLE 228 ROE: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 172
TABLE 229 ROE: WOUND CARE MARKET, BY WOUND TYPE, 2017–2024 (USD MILLION) 172
TABLE 230 ROE: WOUND CARE MARKET, BY END USER, 2017–2024 (USD MILLION) 173
TABLE 231 ROE: WOUND CARE MARKET FOR HOSPITALS & CLINICS, BY SETTING,
2017–2024 (USD MILLION) 173
TABLE 232 APAC: WOUND CARE MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 175
TABLE 233 APAC: WOUND CARE MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 175
TABLE 234 APAC: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 175
TABLE 235 APAC: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2017–2024 (USD MILLION) 176
TABLE 236 APAC: FOAM DRESSINGS MARKET, BY TYPE, 2017–2024 (USD MILLION) 176
TABLE 237 APAC: WOUND THERAPY DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 177
TABLE 238 APAC: NPWT SYSTEMS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 177
TABLE 239 APAC: ACTIVE WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 177
TABLE 240 APAC: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE,
2017–2024 (USD MILLION) 178
TABLE 241 APAC: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 178
TABLE 242 APAC: TISSUE ADHESIVES, SEALANTS, & GLUES MARKET, BY TYPE,
2017–2024 (USD MILLION) 178
TABLE 243 APAC: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 179
TABLE 244 APAC: WOUND CARE MARKET, BY WOUND TYPE, 2017–2024 (USD MILLION) 179
TABLE 245 APAC: WOUND CARE MARKET, BY END USER, 2017–2024 (USD MILLION) 179
TABLE 246 APAC: WOUND CARE MARKET FOR HOSPITALS & CLINICS, BY SETTING,
2017–2024 (USD MILLION) 180
TABLE 247 JAPAN: WOUND CARE MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 180
TABLE 248 JAPAN: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 181
TABLE 249 JAPAN: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2017–2024 (USD MILLION) 181
TABLE 250 JAPAN: FOAM DRESSINGS MARKET, BY TYPE, 2017–2024 (USD MILLION) 181
TABLE 251 JAPAN: WOUND THERAPY DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 182
TABLE 252 JAPAN: NPWT SYSTEMS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 182
TABLE 253 JAPAN: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 182
TABLE 254 JAPAN: TISSUE ADHESIVES, SEALANTS, & GLUES MARKET, BY TYPE,
2017–2024 (USD MILLION) 183
TABLE 255 JAPAN: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 183
TABLE 256 JAPAN: WOUND CARE MARKET, BY WOUND TYPE, 2017–2024 (USD MILLION) 183
TABLE 257 JAPAN: WOUND CARE MARKET, BY END USER, 2017–2024 (USD MILLION) 184
TABLE 258 JAPAN: WOUND CARE MARKET FOR HOSPITALS & CLINICS, BY SETTING,
2017–2024 (USD MILLION) 184
TABLE 259 CHINA: WOUND CARE MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 185
TABLE 260 CHINA: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 185
TABLE 261 CHINA: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2017–2024 (USD MILLION) 186
TABLE 262 CHINA: FOAM DRESSINGS MARKET, BY TYPE, 2017–2024 (USD MILLION) 186
TABLE 263 CHINA: WOUND THERAPY DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 187
TABLE 264 CHINA: NPWT SYSTEMS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 187
TABLE 265 CHINA: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 187
TABLE 266 CHINA: TISSUE ADHESIVES, SEALANTS, & GLUES MARKET, BY TYPE,
2017–2024 (USD MILLION) 188
TABLE 267 CHINA: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 188
TABLE 268 CHINA: WOUND CARE MARKET, BY WOUND TYPE, 2017–2024 (USD MILLION) 188
TABLE 269 CHINA: WOUND CARE MARKET, BY END USER, 2017–2024 (USD MILLION) 189
TABLE 270 CHINA: WOUND CARE MARKET FOR HOSPITALS & CLINICS, BY SETTING,
2017–2024 (USD MILLION) 189
TABLE 271 INDIA: WOUND CARE MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 190
TABLE 272 INDIA: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 190
TABLE 273 INDIA: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2017–2024 (USD MILLION) 191
TABLE 274 INDIA: FOAM DRESSINGS MARKET, BY TYPE, 2017–2024 (USD MILLION) 191
TABLE 275 INDIA: WOUND THERAPY DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 192
TABLE 276 INDIA: NPWT SYSTEMS MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 192
TABLE 277 INDIA: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 192
TABLE 278 INDIA: TISSUE ADHESIVES, SEALANTS, & GLUES MARKET, BY TYPE,
2017–2024 (USD MILLION) 193
TABLE 279 INDIA: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 193
TABLE 280 INDIA: WOUND CARE MARKET, BY WOUND TYPE, 2017–2024 (USD MILLION) 193
TABLE 281 INDIA: WOUND CARE MARKET, BY END USER, 2017–2024 (USD MILLION) 194
TABLE 282 INDIA: WOUND CARE MARKET FOR HOSPITALS & CLINICS, BY SETTING,
2017–2024 (USD MILLION) 194
TABLE 283 AUSTRALIA: WOUND CARE MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 196
TABLE 284 AUSTRALIA: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 196
TABLE 285 AUSTRALIA: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2017–2024 (USD MILLION) 197
TABLE 286 AUSTRALIA: FOAM DRESSINGS MARKET, BY TYPE, 2017–2024 (USD MILLION) 197
TABLE 287 AUSTRALIA: WOUND THERAPY DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 198
TABLE 288 AUSTRALIA: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 198
TABLE 289 AUSTRALIA: TISSUE ADHESIVES, SEALANTS, & GLUES MARKET, BY TYPE,
2017–2024 (USD MILLION) 198
TABLE 290 AUSTRALIA: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 199
TABLE 291 AUSTRALIA: WOUND CARE MARKET, BY WOUND TYPE, 2017–2024 (USD MILLION) 199
TABLE 292 AUSTRALIA: WOUND CARE MARKET, BY END USER, 2017–2024 (USD MILLION) 200
TABLE 293 AUSTRALIA: WOUND CARE MARKET FOR HOSPITALS & CLINICS, BY SETTING, 2017–2024 (USD MILLION) 200
TABLE 294 SOUTH KOREA: WOUND CARE MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 201
TABLE 295 SOUTH KOREA: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 201
TABLE 296 SOUTH KOREA: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2017–2024 (USD MILLION) 202
TABLE 297 SOUTH KOREA: FOAM DRESSINGS MARKET, BY TYPE, 2017–2024 (USD MILLION) 202
TABLE 298 SOUTH KOREA: WOUND THERAPY DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 203
TABLE 299 SOUTH KOREA: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 203
TABLE 300 SOUTH KOREA: TISSUE ADHESIVES, SEALANTS, & GLUES MARKET, BY TYPE, 2017–2024 (USD MILLION) 203
TABLE 301 SOUTH KOREA: TRADITIONAL WOUND CARE PRODUCTS MARKET,
BY TYPE, 2017–2024 (USD MILLION) 204
TABLE 302 SOUTH KOREA: WOUND CARE MARKET, BY WOUND TYPE,
2017–2024 (USD MILLION) 204
TABLE 303 SOUTH KOREA: WOUND CARE MARKET, BY END USER, 2017–2024 (USD MILLION) 204
TABLE 304 SOUTH KOREA: WOUND CARE MARKET FOR HOSPITALS & CLINICS,
BY SETTING, 2017–2024 (USD MILLION) 205
TABLE 305 SINGAPORE: WOUND CARE MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 205
TABLE 306 SINGAPORE: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 206
TABLE 307 SINGAPORE: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2017–2024 (USD MILLION) 206
TABLE 308 SINGAPORE: FOAM DRESSINGS MARKET, BY TYPE, 2017–2024 (USD MILLION) 207
TABLE 309 SINGAPORE: WOUND THERAPY DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 207
TABLE 310 SINGAPORE: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 207
TABLE 311 SINGAPORE: TISSUE ADHESIVES, SEALANTS, & GLUES MARKET, BY TYPE,
2017–2024 (USD MILLION) 208
TABLE 312 SINGAPORE: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 208
TABLE 313 SINGAPORE: WOUND CARE MARKET, BY WOUND TYPE,
2017–2024 (USD MILLION) 208
TABLE 314 SINGAPORE: WOUND CARE MARKET, BY END USER, 2017–2024 (USD MILLION) 209
TABLE 315 SINGAPORE: WOUND CARE MARKET FOR HOSPITALS & CLINICS,
BY SETTING, 2017–2024 (USD MILLION) 209
TABLE 316 ROAPAC: WOUND CARE MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 209
TABLE 317 ROAPAC: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 210
TABLE 318 ROAPAC: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2017–2024 (USD MILLION) 210
TABLE 319 ROAPAC: FOAM DRESSINGS MARKET, BY TYPE, 2017–2024 (USD MILLION) 211
TABLE 320 ROAPAC: WOUND THERAPY DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 211
TABLE 321 ROAPAC: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 211
TABLE 322 ROAPAC: TISSUE ADHESIVES, SEALANTS, & GLUES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 212
TABLE 323 ROAPAC: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 212
TABLE 324 ROAPAC: WOUND CARE MARKET, BY WOUND TYPE, 2017–2024 (USD MILLION) 212
TABLE 325 ROAPAC: WOUND CARE MARKET, BY END USER, 2017–2024 (USD MILLION) 213
TABLE 326 ROAPAC: WOUND CARE MARKET FOR HOSPITALS & CLINICS, BY SETTING,
2017–2024 (USD MILLION) 213
TABLE 327 LATIN AMERICA: WOUND CARE MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 213
TABLE 328 LATIN AMERICA: WOUND CARE MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 214
TABLE 329 LATIN AMERICA: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 214
TABLE 330 LATIN AMERICA: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2017–2024 (USD MILLION) 215
TABLE 331 LATIN AMERICA: FOAM DRESSINGS MARKET, BY TYPE, 2017–2024 (USD MILLION) 215
TABLE 332 LATIN AMERICA: WOUND THERAPY DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 216
TABLE 333 LATIN AMERICA: NPWT SYSTEMS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 216
TABLE 334 LATIN AMERICA: ACTIVE WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 216
TABLE 335 LATIN AMERICA: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE,
2017–2024 (USD MILLION) 217
TABLE 336 LATIN AMERICA: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 217
TABLE 337 LATIN AMERICA: TISSUE ADHESIVES, SEALANTS, & GLUES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 217
TABLE 338 LATIN AMERICA: TRADITIONAL WOUND CARE PRODUCTS MARKET,
BY TYPE, 2017–2024 (USD MILLION) 218
TABLE 339 LATIN AMERICA: WOUND CARE MARKET, BY WOUND TYPE,
2017–2024 (USD MILLION) 218
TABLE 340 LATIN AMERICA: WOUND CARE MARKET, BY END USER,
2017–2024 (USD MILLION) 218
TABLE 341 LATIN AMERICA: WOUND CARE MARKET FOR HOSPITALS & CLINICS, BY SETTING, 2017–2024 (USD MILLION) 219
TABLE 342 BRAZIL: WOUND CARE MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 219
TABLE 343 BRAZIL: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 220
TABLE 344 BRAZIL: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2017–2024 (USD MILLION) 220
TABLE 345 BRAZIL: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 221
TABLE 346 BRAZIL: TISSUE ADHESIVES, SEALANTS, & GLUES MARKET, BY TYPE,
2017–2024 (USD MILLION) 221
TABLE 347 BRAZIL: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 221
TABLE 348 BRAZIL: WOUND CARE MARKET, BY WOUND TYPE, 2017–2024 (USD MILLION) 222
TABLE 349 BRAZIL: WOUND CARE MARKET, BY END USER, 2017–2024 (USD MILLION) 222
TABLE 350 MEXICO: WOUND CARE MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 223
TABLE 351 MEXICO: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 223
TABLE 352 MEXICO: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2017–2024 (USD MILLION) 224
TABLE 353 MEXICO: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 224
TABLE 354 MEXICO: TISSUE ADHESIVES, SEALANTS, & GLUES MARKET, BY TYPE,
2017–2024 (USD MILLION) 225
TABLE 355 MEXICO: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 225
TABLE 356 MEXICO: WOUND CARE MARKET, BY WOUND TYPE, 2017–2024 (USD MILLION) 225
TABLE 357 MEXICO: WOUND CARE MARKET, BY END USER, 2017–2024 (USD MILLION) 226
TABLE 358 REST OF LATAM: WOUND CARE MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 226
TABLE 359 REST OF LATAM: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 226
TABLE 360 REST OF LATAM: ADVANCED WOUND DRESSINGS MARKET, BY TYPE,
2017–2024 (USD MILLION) 227
TABLE 361 REST OF LATAM: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 227
TABLE 362 REST OF LATAM: TISSUE ADHESIVES, SEALANTS, & GLUES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 228
TABLE 363 REST OF LATAM: WOUND CARE MARKET, BY WOUND TYPE,
2017–2024 (USD MILLION) 228
TABLE 364 REST OF LATAM: WOUND CARE MARKET, BY END USER,
2017–2024 (USD MILLION) 228
TABLE 365 MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 229
TABLE 366 MIDDLE EAST & AFRICA: ADVANCED WOUND CARE PRODUCTS MARKET,
BY TYPE, 2017–2024 (USD MILLION) 229
TABLE 367 MIDDLE EAST & AFRICA: ADVANCED WOUND DRESSINGS MARKET,
BY TYPE, 2017–2024 (USD MILLION) 230
TABLE 368 MIDDLE EAST & AFRICA: FOAM DRESSINGS MARKET, BY TYPE,
2017–2024 (USD MILLION) 230
TABLE 369 MIDDLE EAST & AFRICA: WOUND THERAPY DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 231
TABLE 370 MIDDLE EAST & AFRICA: NPWT SYSTEMS MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 231
TABLE 371 MIDDLE EAST & AFRICA: ACTIVE WOUND CARE PRODUCTS MARKET,
BY TYPE, 2017–2024 (USD MILLION) 231
TABLE 372 MIDDLE EAST & AFRICA: BIOLOGICAL SKIN SUBSTITUTES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 232
TABLE 373 MIDDLE EAST & AFRICA: SURGICAL WOUND CARE PRODUCTS MARKET,
BY TYPE, 2017–2024 (USD MILLION) 232
TABLE 374 MIDDLE EAST & AFRICA: TISSUE ADHESIVES, SEALANTS, & GLUES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 232
TABLE 375 MIDDLE EAST & AFRICA: TRADITIONAL WOUND CARE PRODUCTS MARKET,
BY TYPE, 2017–2024 (USD MILLION) 233
TABLE 376 MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY WOUND TYPE,
2017–2024 (USD MILLION) 233
TABLE 377 MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY END USER,
2017–2024 (USD MILLION) 233
TABLE 378 MIDDLE EAST & AFRICA: WOUND CARE MARKET FOR HOSPITALS & CLINICS,
BY SETTING, 2017–2024 (USD MILLION) 234
TABLE 379 TRADITIONAL AND SURGICAL WOUND CARE PRODUCTS MARKET SHARE,
BY COMPANY, 2018 237
TABLE 380 PARTNERSHIPS, AGREEMENTS, CONTRACTS, & COLLABORATIONS (2016–2019) 238
TABLE 381 PRODUCT LAUNCHES, UPGRADES, & APPROVALS (2016–2019) 239
TABLE 382 ACQUISITIONS (2016–2019) 239
TABLE 383 EXPANSIONS (2016–2019) 240   

 

LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 35
FIGURE 2 KEY DATA FROM SECONDARY SOURCES 36
FIGURE 3 KEY DATA FROM PRIMARY SOURCES 37
FIGURE 4 KEY INDUSTRY INSIGHTS 38
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS 38
FIGURE 6 BOTTOM-UP APPROACH 39
FIGURE 7 TOP-DOWN APPROACH 40
FIGURE 8 DATA TRIANGULATION METHODOLOGY 41
FIGURE 9 ASSUMPTIONS FOR THE STUDY 42
FIGURE 10 WOUND CARE MARKET, BY PRODUCT, 2019 VS. 2024 (USD BILLION) 43
FIGURE 11 WOUND CARE MARKET, BY WOUND TYPE, 2019 VS. 2024 (USD BILLION) 44
FIGURE 12 WOUND CARE MARKET, BY END USER, 2019 VS. 2024 (USD BILLION) 44
FIGURE 13 WOUND CARE MARKET, BY REGION, 2019 VS. 2024 (USD BILLION) 45
FIGURE 14 GROWING PREVALENCE OF DISEASES AND CONDITIONS AFFECTING WOUND HEALING CAPABILITIES TO DRIVE MARKET GROWTH DURING
THE FORECAST PERIOD 46
FIGURE 15 HOSPITALS & CLINICS DOMINATED THE NORTH AMERICAN WOUND
CARE MARKET IN 2018 47
FIGURE 16 COUNTRIES IN APAC TO REGISTER THE HIGHEST CAGR DURING
THE FORECAST PERIOD 48
FIGURE 17 WOUND CARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND TRENDS 49
FIGURE 18 INCIDENCE OF DIABETES, BY REGION, 2015 VS. 2040 (MILLION CASES) 50
FIGURE 19 WOUND CARE RESEARCH PATENTS, BY COUNTRY (2015–2017) 55
FIGURE 20 NORTH AMERICA: MARKET SNAPSHOT 119
FIGURE 21 APAC: MARKET SNAPSHOT 174
FIGURE 22 DIABETES BURDEN IN AUSTRALIA, BY AGE GROUP (2014–2015) 195
FIGURE 23 KEY DEVELOPMENTS IN THE WOUND CARE MARKET (2016–2019) 235
FIGURE 24 NPWT SYSTEMS MARKET SHARE, BY COMPANY (2018) 236
FIGURE 25 ADVANCED WOUND DRESSINGS MARKET SHARE, BY COMPANY (2018) 236
FIGURE 26 ACTIVE WOUND CARE PRODUCTS MARKET SHARE, BY COMPANY (2018) 237
FIGURE 27 SURGICAL SUTURES MARKET SHARE, BY COMPANY (2018) 238
FIGURE 28 WOUND CARE MARKET: COMPETITIVE LEADERSHIP MAPPING, 2018 241
FIGURE 29 SMITH & NEPHEW PLC: COMPANY SNAPSHOT (2018) 244
FIGURE 30 MÖLNLYCKE HEALTH CARE AB: COMPANY SNAPSHOT (2018) 248
FIGURE 31 BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT (2018) 252
FIGURE 32 ACELITY L.P. INC.: COMPANY SNAPSHOT (2018) 255
FIGURE 33 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT (2018) 258
FIGURE 34 CONVATEC GROUP PLC: COMPANY SNAPSHOT (2018) 261
FIGURE 35 COLOPLAST A/S: COMPANY SNAPSHOT (2018) 264
FIGURE 36 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2018) 266
FIGURE 37 MEDTRONIC PLC: COMPANY SNAPSHOT (2018) 269
FIGURE 38 3M COMPANY: COMPANY SNAPSHOT (2018) 272
FIGURE 39 PAUL HARTMANN AG: COMPANY SNAPSHOT (2018) 275
FIGURE 40 MIMEDX GROUP: COMPANY SNAPSHOT (2016) 277

 

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る